| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caspases | 22 | 2022 | 166 | 5.750 |
Why?
|
| Apoptosis | 35 | 2024 | 1901 | 4.000 |
Why?
|
| Caspase 2 | 12 | 2024 | 27 | 3.840 |
Why?
|
| DNA Damage | 10 | 2024 | 511 | 1.420 |
Why?
|
| Luminescent Proteins | 5 | 2016 | 165 | 1.200 |
Why?
|
| Inflammasomes | 5 | 2022 | 167 | 1.100 |
Why?
|
| NF-kappa B | 4 | 2023 | 454 | 1.060 |
Why?
|
| Enzyme Activation | 12 | 2017 | 618 | 1.030 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2023 | 770 | 0.940 |
Why?
|
| Cell Cycle | 4 | 2023 | 607 | 0.870 |
Why?
|
| Nuclear Proteins | 4 | 2024 | 1285 | 0.850 |
Why?
|
| Ribosomes | 1 | 2023 | 125 | 0.750 |
Why?
|
| Single-Cell Analysis | 2 | 2016 | 347 | 0.750 |
Why?
|
| Signal Transduction | 10 | 2023 | 4720 | 0.710 |
Why?
|
| Microscopy, Confocal | 9 | 2022 | 364 | 0.700 |
Why?
|
| Microscopy, Fluorescence | 4 | 2017 | 327 | 0.670 |
Why?
|
| Cell Nucleolus | 2 | 2017 | 50 | 0.670 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 4 | 2017 | 9 | 0.630 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 570 | 0.580 |
Why?
|
| Fluorescence | 2 | 2018 | 102 | 0.580 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2015 | 72 | 0.550 |
Why?
|
| Stress, Physiological | 2 | 2010 | 260 | 0.550 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1829 | 0.550 |
Why?
|
| Cell Proliferation | 2 | 2024 | 2511 | 0.530 |
Why?
|
| Inflammation | 5 | 2022 | 1522 | 0.520 |
Why?
|
| Caspase 1 | 2 | 2015 | 49 | 0.520 |
Why?
|
| Cysteine Endopeptidases | 2 | 2017 | 112 | 0.480 |
Why?
|
| Genes, Transgenic, Suicide | 2 | 2015 | 48 | 0.470 |
Why?
|
| Optical Imaging | 1 | 2016 | 73 | 0.470 |
Why?
|
| Caspase 9 | 2 | 2015 | 76 | 0.460 |
Why?
|
| Animals | 31 | 2024 | 34850 | 0.440 |
Why?
|
| Boronic Acids | 1 | 2014 | 47 | 0.440 |
Why?
|
| Transfection | 6 | 2018 | 996 | 0.430 |
Why?
|
| Pyrazines | 1 | 2014 | 72 | 0.430 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 333 | 0.430 |
Why?
|
| Mitochondria | 10 | 2010 | 751 | 0.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 623 | 0.380 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 930 | 0.380 |
Why?
|
| Cell Death | 6 | 2022 | 243 | 0.370 |
Why?
|
| Macrophages | 3 | 2022 | 692 | 0.350 |
Why?
|
| Cytoplasm | 2 | 2009 | 269 | 0.350 |
Why?
|
| Humans | 45 | 2024 | 132256 | 0.340 |
Why?
|
| Mutation | 3 | 2024 | 6250 | 0.340 |
Why?
|
| HeLa Cells | 10 | 2017 | 731 | 0.330 |
Why?
|
| Carrier Proteins | 6 | 2010 | 1050 | 0.330 |
Why?
|
| Mice | 16 | 2024 | 18507 | 0.330 |
Why?
|
| Fas Ligand Protein | 1 | 2010 | 37 | 0.320 |
Why?
|
| Heat-Shock Response | 1 | 2010 | 37 | 0.320 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 60 | 0.320 |
Why?
|
| Cells, Cultured | 9 | 2021 | 3046 | 0.310 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 92 | 0.310 |
Why?
|
| Neoplasm Proteins | 3 | 2005 | 702 | 0.300 |
Why?
|
| Caspases, Initiator | 2 | 2021 | 6 | 0.290 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 430 | 0.280 |
Why?
|
| Mitochondrial Membranes | 4 | 2015 | 32 | 0.280 |
Why?
|
| Anemia, Sickle Cell | 2 | 2022 | 330 | 0.280 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 1997 | 0.270 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 3691 | 0.270 |
Why?
|
| Genomic Instability | 2 | 2022 | 246 | 0.270 |
Why?
|
| Hot Temperature | 3 | 2015 | 141 | 0.240 |
Why?
|
| Neoplasms | 1 | 2020 | 2961 | 0.230 |
Why?
|
| Pyroptosis | 2 | 2022 | 30 | 0.220 |
Why?
|
| Cell Self Renewal | 1 | 2024 | 49 | 0.220 |
Why?
|
| CARD Signaling Adaptor Proteins | 3 | 2015 | 42 | 0.210 |
Why?
|
| Models, Molecular | 2 | 2020 | 1120 | 0.210 |
Why?
|
| Oncolytic Virotherapy | 2 | 2015 | 89 | 0.210 |
Why?
|
| Polyploidy | 1 | 2023 | 18 | 0.210 |
Why?
|
| I-kappa B Kinase | 1 | 2023 | 58 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 7 | 2015 | 170 | 0.200 |
Why?
|
| Transcription Factors | 2 | 2010 | 2491 | 0.200 |
Why?
|
| Autophagy | 2 | 2022 | 426 | 0.200 |
Why?
|
| Tubulin Modulators | 2 | 2015 | 11 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 3 | 2005 | 764 | 0.190 |
Why?
|
| Adenoviridae | 2 | 2015 | 596 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 761 | 0.190 |
Why?
|
| Protein Multimerization | 2 | 2015 | 151 | 0.180 |
Why?
|
| Immunity | 1 | 2002 | 183 | 0.180 |
Why?
|
| Gene Expression Regulation | 4 | 2023 | 2442 | 0.180 |
Why?
|
| Genetic Vectors | 2 | 2015 | 927 | 0.170 |
Why?
|
| Cytochromes c | 7 | 2011 | 53 | 0.170 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 351 | 0.170 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2011 | 40 | 0.170 |
Why?
|
| Erythrocytes | 1 | 2021 | 201 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2015 | 180 | 0.160 |
Why?
|
| Heat Shock Transcription Factors | 2 | 2010 | 20 | 0.160 |
Why?
|
| Cell Membrane Permeability | 3 | 2010 | 72 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 491 | 0.150 |
Why?
|
| Bortezomib | 2 | 2016 | 70 | 0.140 |
Why?
|
| CRADD Signaling Adaptor Protein | 3 | 2017 | 4 | 0.140 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2015 | 87 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2005 | 613 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1965 | 0.130 |
Why?
|
| Chromosomal Instability | 1 | 2016 | 60 | 0.130 |
Why?
|
| Mice, Knockout | 6 | 2017 | 3868 | 0.120 |
Why?
|
| Time Factors | 3 | 2015 | 6452 | 0.120 |
Why?
|
| Aneuploidy | 1 | 2016 | 143 | 0.120 |
Why?
|
| Time-Lapse Imaging | 1 | 2016 | 8 | 0.120 |
Why?
|
| Lactones | 1 | 2016 | 37 | 0.120 |
Why?
|
| Proteasome Inhibitors | 1 | 2016 | 61 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 395 | 0.120 |
Why?
|
| NLR Proteins | 1 | 2015 | 2 | 0.120 |
Why?
|
| Caspase 12 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cholera Toxin | 1 | 2015 | 51 | 0.120 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 4 | 2011 | 8 | 0.110 |
Why?
|
| Luciferases, Firefly | 1 | 2014 | 12 | 0.110 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 11 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2015 | 63 | 0.110 |
Why?
|
| Organic Chemicals | 1 | 2014 | 59 | 0.110 |
Why?
|
| RNA Interference | 3 | 2017 | 515 | 0.110 |
Why?
|
| Plasmids | 1 | 2016 | 459 | 0.110 |
Why?
|
| Dimerization | 1 | 2014 | 149 | 0.110 |
Why?
|
| Intracellular Membranes | 2 | 2005 | 59 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 2062 | 0.110 |
Why?
|
| Pyrroles | 1 | 2016 | 182 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2014 | 302 | 0.110 |
Why?
|
| Jurkat Cells | 3 | 2010 | 86 | 0.110 |
Why?
|
| Permeability | 6 | 2015 | 117 | 0.110 |
Why?
|
| Vincristine | 1 | 2015 | 196 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 282 | 0.110 |
Why?
|
| Oncolytic Viruses | 1 | 2014 | 76 | 0.100 |
Why?
|
| Annexin A5 | 2 | 2003 | 19 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 398 | 0.100 |
Why?
|
| Cloning, Molecular | 1 | 2014 | 811 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2014 | 604 | 0.100 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 102 | 0.100 |
Why?
|
| Models, Biological | 3 | 2010 | 1445 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2015 | 413 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 605 | 0.090 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2013 | 138 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2016 | 374 | 0.090 |
Why?
|
| Mitochondria, Liver | 1 | 2011 | 34 | 0.090 |
Why?
|
| Heme | 2 | 2022 | 52 | 0.090 |
Why?
|
| Hemolysis | 2 | 2022 | 107 | 0.090 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 163 | 0.090 |
Why?
|
| Peptides | 1 | 2015 | 844 | 0.090 |
Why?
|
| Kinetics | 2 | 2009 | 1130 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2015 | 720 | 0.080 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2009 | 6 | 0.080 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2009 | 12 | 0.080 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2010 | 74 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 635 | 0.080 |
Why?
|
| Cell Survival | 2 | 2012 | 868 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 310 | 0.080 |
Why?
|
| Cytological Techniques | 1 | 2009 | 17 | 0.080 |
Why?
|
| Neuroblastoma | 1 | 2014 | 550 | 0.070 |
Why?
|
| Biosensing Techniques | 1 | 2009 | 67 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2014 | 749 | 0.070 |
Why?
|
| Disease | 1 | 2010 | 127 | 0.070 |
Why?
|
| Membrane Glycoproteins | 2 | 2000 | 421 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 685 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 47 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 686 | 0.070 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 21 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1683 | 0.070 |
Why?
|
| Microscopy | 1 | 2008 | 120 | 0.070 |
Why?
|
| bcl-X Protein | 4 | 2011 | 32 | 0.070 |
Why?
|
| Binding Sites | 1 | 2010 | 1256 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 4 | 2011 | 71 | 0.060 |
Why?
|
| Bystander Effect | 1 | 2006 | 6 | 0.060 |
Why?
|
| Protein Binding | 4 | 2017 | 1734 | 0.060 |
Why?
|
| Iodine Radioisotopes | 2 | 2003 | 75 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1284 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 2669 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2005 | 592 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 1757 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1541 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 89 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2005 | 651 | 0.050 |
Why?
|
| Drug Design | 1 | 2005 | 161 | 0.050 |
Why?
|
| Aging | 1 | 2011 | 1254 | 0.050 |
Why?
|
| Sarcoma, Experimental | 1 | 2003 | 16 | 0.050 |
Why?
|
| Fibrosarcoma | 1 | 2003 | 26 | 0.050 |
Why?
|
| Research Design | 1 | 2008 | 743 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2017 | 799 | 0.050 |
Why?
|
| Mitochondrial Proteins | 3 | 2010 | 260 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2022 | 11 | 0.050 |
Why?
|
| Caspase Inhibitors | 1 | 2022 | 35 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 170 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 2015 | 366 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2022 | 141 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 143 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 998 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 90 | 0.040 |
Why?
|
| Alarmins | 1 | 2021 | 5 | 0.040 |
Why?
|
| Cell Line | 2 | 2009 | 2724 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 129 | 0.040 |
Why?
|
| Cytokines | 2 | 2019 | 1365 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2005 | 800 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2002 | 364 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 589 | 0.040 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 16 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 3771 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2000 | 182 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2015 | 441 | 0.040 |
Why?
|
| Haplotypes | 1 | 2000 | 545 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 881 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 2017 | 20 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 666 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2000 | 369 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2015 | 862 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 129 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2016 | 39 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 201 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2015 | 47 | 0.030 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2015 | 21 | 0.030 |
Why?
|
| Nitrophenols | 1 | 2015 | 16 | 0.030 |
Why?
|
| Staurosporine | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2015 | 6 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2015 | 60 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 56 | 0.030 |
Why?
|
| Genotype | 2 | 2017 | 2703 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 251 | 0.030 |
Why?
|
| Cytosol | 2 | 2006 | 144 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 1134 | 0.030 |
Why?
|
| Sepsis | 1 | 2019 | 516 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 217 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 294 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 421 | 0.030 |
Why?
|
| Ultraviolet Rays | 2 | 2005 | 198 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 336 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 4690 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 316 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2015 | 347 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 2 | 2003 | 38 | 0.030 |
Why?
|
| Isotope Labeling | 2 | 2003 | 92 | 0.020 |
Why?
|
| Piperazines | 1 | 2015 | 255 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2015 | 284 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 85 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 1080 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 69 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 100 | 0.020 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 14 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 801 | 0.020 |
Why?
|
| Virus Replication | 1 | 2015 | 636 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 1045 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 4758 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1671 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 535 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 157 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2014 | 499 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1563 | 0.020 |
Why?
|
| Mammals | 1 | 2011 | 271 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 615 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2013 | 359 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2010 | 1597 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 287 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1612 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 579 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 4540 | 0.020 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2005 | 13 | 0.010 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2005 | 19 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 196 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 2004 | 14 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 161 | 0.010 |
Why?
|
| Thionucleosides | 1 | 2003 | 6 | 0.010 |
Why?
|
| Deoxyadenosines | 1 | 2003 | 9 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 118 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 124 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2003 | 138 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2004 | 221 | 0.010 |
Why?
|
| Trimethyltin Compounds | 1 | 2003 | 2 | 0.010 |
Why?
|
| Chloramines | 1 | 2003 | 5 | 0.010 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 24 | 0.010 |
Why?
|
| Radioactive Tracers | 1 | 2003 | 20 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2003 | 32 | 0.010 |
Why?
|
| Drug Stability | 1 | 2003 | 59 | 0.010 |
Why?
|
| Liposomes | 1 | 2004 | 203 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 380 | 0.010 |
Why?
|
| Benzoates | 1 | 2003 | 22 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 275 | 0.010 |
Why?
|
| Camptothecin | 1 | 2003 | 74 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 862 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1350 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 448 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 826 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2003 | 194 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2003 | 239 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 802 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2000 | 49 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 24 | 0.010 |
Why?
|
| Female | 3 | 2015 | 70791 | 0.010 |
Why?
|
| Family Health | 1 | 2000 | 256 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 268 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 348 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2000 | 246 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2000 | 750 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2000 | 618 | 0.010 |
Why?
|
| Alleles | 1 | 2000 | 1685 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 1479 | 0.010 |
Why?
|
| Male | 1 | 2000 | 65018 | 0.000 |
Why?
|